Table of Content

1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17

2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 33
2.4 Emerging Opportunities and Market Trends 36
2.5 Porter’s Fiver Forces Analysis 40

3 Segmentation of North America Market by Offering 44
3.1 Market Overview by Offering 44
3.2 Instruments 46
3.3 Test Kits & Consumables 48
3.3.1 Kits & Assays 49
3.3.2 Consumables 51
3.4 Software & Services 53

4 Segmentation of North America Market by Transplant 55
4.1 Market Overview by Transplant 55
4.2 Solid Organ Transplant 57
4.2.1 Kidney 59
4.2.2 Liver 60
4.2.3 Heart 61
4.2.4 Lung 62
4.2.5 Pancreas 63
4.2.6 Kidney-Pancreas 64
4.2.7 Other Solid Organ Transplants 65
4.3 Stem Cell Transplant 66
4.4 Soft Tissue Transplant 67

5 Segmentation of North America Market by Application 68
5.1 Market Overview by Application 68
5.2 Diagnostics 70
5.2.1 Donor Testing 71
5.2.2 Recipient Testing 72
5.3 Translational Research 73

6 Segmentation of North America Market by Technology 74
6.1 Market Overview by Technology 74
6.2 Molecular Technologies 76
6.2.1 PCR 78
6.2.2 Sequencing 79
6.2.3 Other Molecular Technologies 80
6.3 Serology 81
6.4 Flow Cytometry 82
6.5 Other Technologies 83

7 Segmentation of North America Market by End User 84
7.1 Market Overview by End User 84
7.2 Hospitals and Transplant Centers 86
7.3 Reference Laboratories 87
7.4 Academic and Research Institutions 88
7.5 Other End Users 89

8 North America Market 2021-2031 by Country 90
8.1 Overview of North America Market 90
8.2 U.S. 93
8.3 Canada 96
8.4 Mexico 98

9 Competitive Landscape 100
9.1 Overview of Key Vendors 100
9.2 New Product Launch, Partnership, Investment, and M&A 103
9.3 Company Profiles 104
Abbott Laboratories Inc. 104
ARUP Laboratories 106
BAG Health Care GmbH 107
Becton Dickinson and Company 108
bioM?rieux S.A. 109
Bio-Rad Laboratories, Inc. 110
CareDx, Inc. 111
Eurofins Scientific 112
F. Hoffmann-La Roche Ltd. 113
Illumina, Inc. 114
Immucor, Inc. 115
Laboratory Corporation of America Holdings 116
Novacyt Group 117
Omixon Ltd. 118
OPKO Health 119
QIAGEN N.V. 120
Quest Diagnostics Incorporated 121
Thermo Fisher Scientific Inc. 122
RELATED REPORTS 123



List of Figures

List of Figures:

Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. North America Organ Transplant Diagnostics Market, 2021-2031, $ mn 20
Figure 5. Impact of COVID-19 on Business 25
Figure 6. Primary Drivers and Impact Factors of North America Organ Transplant Diagnostics Market 27
Figure 7. Leading Causes of Death in the World, 2019-2020, million 30
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 31
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 31
Figure 10. Primary Restraints and Impact Factors of North America Organ Transplant Diagnostics Market 33
Figure 11. Investment Opportunity Analysis 37
Figure 12. Porter’s Fiver Forces Analysis of North America Organ Transplant Diagnostics Market 40
Figure 13. Breakdown of North America Organ Transplant Diagnostics Market by Offering, 2021-2031, % of Revenue 45
Figure 14. North America Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%) 45
Figure 15. North America Organ Transplant Diagnostics Market by Offering: Instruments, 2021-2031, $ mn 46
Figure 16. North America Organ Transplant Diagnostics Market by Offering: Test Kits & Consumables, 2021-2031, $ mn 48
Figure 17. North America Organ Transplant Diagnostics Market by Test Kits & Consumables: Kits & Assays, 2021-2031, $ mn 49
Figure 18. North America Organ Transplant Diagnostics Market by Test Kits & Consumables: Consumables, 2021-2031, $ mn 51
Figure 19. North America Organ Transplant Diagnostics Market by Offering: Software & Services, 2021-2031, $ mn 53
Figure 20. Breakdown of North America Organ Transplant Diagnostics Market by Transplant, 2021-2031, % of Sales Revenue 56
Figure 21. North America Addressable Market Cap in 2022-2031 by Transplant, Value ($ mn) and Share (%) 56
Figure 22. North America Organ Transplant Diagnostics Market by Transplant: Solid Organ Transplant, 2021-2031, $ mn 57
Figure 23. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Kidney, 2021-2031, $ mn 59
Figure 24. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Liver, 2021-2031, $ mn 60
Figure 25. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Heart, 2021-2031, $ mn 61
Figure 26. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Lung, 2021-2031, $ mn 62
Figure 27. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Pancreas, 2021-2031, $ mn 63
Figure 28. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Kidney-Pancreas, 2021-2031, $ mn 64
Figure 29. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Other Solid Organ Transplants, 2021-2031, $ mn 65
Figure 30. North America Organ Transplant Diagnostics Market by Transplant: Stem Cell Transplant, 2021-2031, $ mn 66
Figure 31. North America Organ Transplant Diagnostics Market by Transplant: Soft Tissue Transplant, 2021-2031, $ mn 67
Figure 32. Breakdown of North America Organ Transplant Diagnostics Market by Application, 2021-2031, % of Sales Revenue 69
Figure 33. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 69
Figure 34. North America Organ Transplant Diagnostics Market by Application: Diagnostics, 2021-2031, $ mn 70
Figure 35. North America Organ Transplant Diagnostics Market by Diagnostics: Donor Testing, 2021-2031, $ mn 71
Figure 36. North America Organ Transplant Diagnostics Market by Diagnostics: Recipient Testing, 2021-2031, $ mn 72
Figure 37. North America Organ Transplant Diagnostics Market by Application: Translational Research, 2021-2031, $ mn 73
Figure 38. Breakdown of North America Organ Transplant Diagnostics Market by Technology, 2021-2031, % of Revenue 75
Figure 39. North America Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 75
Figure 40. North America Organ Transplant Diagnostics Market by Technology: Molecular Technologies, 2021-2031, $ mn 76
Figure 41. North America Organ Transplant Diagnostics Market by Molecular Technologies: PCR, 2021-2031, $ mn 78
Figure 42. North America Organ Transplant Diagnostics Market by Molecular Technologies: Sequencing, 2021-2031, $ mn 79
Figure 43. North America Organ Transplant Diagnostics Market by Molecular Technologies: Other Molecular Technologies, 2021-2031, $ mn 80
Figure 44. North America Organ Transplant Diagnostics Market by Technology: Serology, 2021-2031, $ mn 81
Figure 45. North America Organ Transplant Diagnostics Market by Technology: Flow Cytometry, 2021-2031, $ mn 82
Figure 46. North America Organ Transplant Diagnostics Market by Technology: Other Technologies, 2021-2031, $ mn 83
Figure 47. Breakdown of North America Organ Transplant Diagnostics Market by End User, 2021-2031, % of Revenue 85
Figure 48. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 85
Figure 49. North America Organ Transplant Diagnostics Market by End User: Hospitals and Transplant Centers, 2021-2031, $ mn 86
Figure 50. North America Organ Transplant Diagnostics Market by End User: Reference Laboratories, 2021-2031, $ mn 87
Figure 51. North America Organ Transplant Diagnostics Market by End User: Academic and Research Institutions, 2021-2031, $ mn 88
Figure 52. North America Organ Transplant Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 89
Figure 53. Breakdown of North America Organ Transplant Diagnostics Market by Country, 2021 and 2031, % of Revenue 91
Figure 54. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 92
Figure 55. U.S. Organ Transplant Diagnostics Market, 2021-2031, $ mn 94
Figure 56. Canada Organ Transplant Diagnostics Market, 2021-2031, $ mn 96
Figure 57. Organ Transplant Diagnostics Market in Mexico, 2021-2031, $ mn 98
Figure 58. Growth Stage of North America Organ Transplant Diagnostics Industry over the Forecast Period 100

List of Tables

List of Tables:

Table 1. Snapshot of North America Organ Transplant Diagnostics Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Economic Outlook, 2021-2023 23
Table 4. World Health Spending by Region, $ bn, 2013-2020 32
Table 5. Main Product Trends and Market Opportunities in North America Organ Transplant Diagnostics Market 36
Table 6. North America Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 44
Table 7. Main Platforms and Key Vendors 47
Table 8. North America Organ Transplant Diagnostics Market: Test Kits & Consumables by Type, 2021-2031, $ mn 48
Table 9. Main Kits & Assays and Key Vendors 50
Table 10. Main Consumables and Key Vendors 52
Table 11. Main Services and Key Vendors 54
Table 12. North America Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 55
Table 13. North America Organ Transplant Diagnostics Market: Solid Organ Transplant by Type, 2021-2031, $ mn 58
Table 14. North America Organ Transplant Diagnostics Market by Application, 2021-2031, $ mn 68
Table 15. North America Organ Transplant Diagnostics Market: Diagnostics by Type, 2021-2031, $ mn 70
Table 16. North America Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 74
Table 17. North America Organ Transplant Diagnostics Market: Molecular Technologies by Type, 2021-2031, $ mn 77
Table 18. North America Organ Transplant Diagnostics Market by End User, 2021-2031, $ mn 84
Table 19. North America Organ Transplant Diagnostics Market by Country, 2021-2031, $ mn 91
Table 20. U.S. Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 95
Table 21. U.S. Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 95
Table 22. U.S. Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 95
Table 23. Canada Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 97
Table 24. Canada Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 97
Table 25. Canada Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 97
Table 26. Mexico Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 99
Table 27. Mexico Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 99
Table 28. Mexico Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 99
Table 29. Abbott Laboratories Inc.: Company Snapshot 104
Table 30. Abbott Laboratories Inc.: Business Segmentation 105
Table 31. Abbott Laboratories Inc.: Product Portfolio 105